STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $94.3 million in its fourth quarter.

The Stamford, Connecticut-based company said it had a loss of $1.44 per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.25 per share.

The biopharmaceutical company posted revenue of $5.4 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $1.3 million.

For the year, the company reported a loss of $325.1 million, or $5.15 per share. Revenue was reported as $5.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWTX at https://www.zacks.com/ap/SWTX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News